Fundraising FoxHealthtech Startups
18,759 companies tagged Healthtech, with their investors and founders.
A radiation oncology center offering proton therapy for cancer patients of all ages and diagnoses, with a clinical team of physicians and supporting staff. It participates in national clinical trials as part of its cancer treatment services.
0 investors
Okogen is a clinical-stage ophthalmic pharmaceutical company developing a treatment for acute infectious conjunctivitis, covering both bacterial and viral forms. Its lead product is in clinical trials as a single treatment for all forms of the condition.
0 investors
0 investors
0 investors
0 investors
0 investors
Oleander Medical Technologies develops Targeted Osmotic Lysis, a medical technology approach for treating cancer in animals. The company works with veterinary hospitals and regulatory consultants to advance its therapeutic platform.
0 investors
0 investors
0 investors
Ōmcare offers the Home Health Hub, a device combining automated medication dispensing, visual adherence verification, one-touch video calls, and remote monitoring for seniors aging at home. Sold through home care agencies and pharmacy partners, it helps older adults manage medications while giving families and healthcare providers remote visibility.
0 investors
Omega Ophthalmics develops the Gemini Capsule, an implantable device that maintains the capsular bag in an open configuration after cataract removal and provides a stable position for intraocular lens implantation. The product is used in ophthalmic surgery.
0 investors
0 investors
0 investors
OmnicureMD offers a Tele-ICU (Tele-Critical Care) platform built by an intensivist-led team to provide remote critical care support to healthcare providers. The company positions its service as a more accessible, scalable alternative to capital-intensive legacy Tele-ICU systems.
0 investors
0 investors
OncBioMune is a clinical-stage biopharmaceutical company developing novel cancer immunotherapy products using proprietary vaccine technology designed to stimulate immune response against cancer cells. The company focuses on treatments for prostate cancer and other oncology indications, with its lead product in Phase 2 development.
0 investors
ONclick Health provides healthcare staffing and recruitment services, leveraging decades of experience in healthcare operations and leadership.
0 investors
0 investors
Oncobiomix develops AI-powered microbiome diagnostics and therapeutics, using gut microbiome analysis as a "biosensor" for cancer detection and gut health. The company offers microbiome testing (RebiomiX) in which samples undergo microbial DNA extraction and AI-based analysis to generate health reports.
0 investors
Insight Molecular Diagnostics (iMDx) develops molecular diagnostic tests for transplantation and oncology, including blood-based donor-derived cell-free DNA assays for transplant monitoring and gene-expression tests for cancer immunotherapy guidance. Its products serve researchers, clinicians, hospitals, and healthcare systems across clinical practice and translational research.
0 investors
0 investors
0 investors
The Oncology Institute operates a national network of 65 affiliated physician clinics and contracts with independently-owned oncology and hematology practices to deliver outpatient cancer care through fee-for-service arrangements and value-based contracts that shift financial risk to the company. The company also operates specialty pharmacies and clinical research services, serving approximately 2 million patients across 17 markets through capitation, gain-sharing, and full delegation contracting models designed to reduce treatment costs while maintaining clinical quality standards.
0 investors
Onconetix is a commercial-stage biotechnology company that researches, develops, and commercializes proprietary therapeutics, diagnostics, and services in oncology. It serves clinicians and patients, with a product line that includes the Proclarix diagnostic.
0 investors